RAPP
Rapport Therapeutics
RAPP
RAPP
147 hedge funds and large institutions have $1.64B invested in Rapport Therapeutics in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 53 increasing their positions, 34 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
6% more capital invested
Capital invested by funds: $1.55B → $1.64B (+$91.6M)
2.61% more ownership
Funds ownership: 107.18% → 109.8% (+2.6%)
2% more funds holding
Funds holding: 144 → 147 (+3)
Holders
147
Holding in Top 10
6
Calls
$638K
Puts
$441K
Top Buyers
| 1 | +$17.9M | |
| 2 | +$15.1M | |
| 3 | +$9.18M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$5.23M |
| 5 |
SCM
Sio Capital Management
New York
|
+$5.11M |
Top Sellers
| 1 | -$8.57M | |
| 2 | -$3.94M | |
| 3 | -$3.07M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.68M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$2.6M |
